An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still ...

Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer. Bristol Myers on Friday ...

Doctors warn, fatty liver can lead to liver cancer if ignored! Here's how to prevent non-alcoholic fatty liver disease.

The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

Discover the distinctive symptoms of liver pain, common underlying conditions, and effective treatment options to protect ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

The groundbreaking study demonstrates drug candidate can safely and effectively target and eliminate senescent cells, also known as “zombie cells,” from the liver.

Liver cancer might be on the rise as a silent epidemic. However, awareness coupled with cutting-edge treatments turn out to be a boon for the same. While Cutting-edge technology can offer ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...